These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 11754489

  • 1. Striatal dopamine output is compromised within +/- BDNF mice.
    Dluzen DE, Anderson LI, McDermott JL, Kucera J, Walro JM.
    Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489
    [Abstract] [Full Text] [Related]

  • 2. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice.
    Dluzen DE.
    Neurosci Lett; 2004 Apr 15; 359(3):135-8. PubMed ID: 15050682
    [Abstract] [Full Text] [Related]

  • 3. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B, Dluzen DE.
    Synapse; 2006 Oct 15; 60(5):354-61. PubMed ID: 16838362
    [Abstract] [Full Text] [Related]

  • 4. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
    Joyce JN, Renish L, Osredkar T, Walro JM, Kucera J, Dluzen DE.
    Synapse; 2004 Apr 15; 52(1):11-9. PubMed ID: 14755628
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice.
    Dluzen DE, Gao X, Story GM, Anderson LI, Kucera J, Walro JM.
    Exp Neurol; 2001 Jul 15; 170(1):121-8. PubMed ID: 11421589
    [Abstract] [Full Text] [Related]

  • 7. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
    Liu B, Dluzen DE.
    Neuroendocrinology; 2006 Jul 15; 83(5-6):295-302. PubMed ID: 16926530
    [Abstract] [Full Text] [Related]

  • 8. Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.
    Dluzen DE, Salvaterra TJ.
    Neuroendocrinology; 2005 Jul 15; 82(2):78-86. PubMed ID: 16415598
    [Abstract] [Full Text] [Related]

  • 9. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct 15; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 10. Age-related changes in nigrostriatal dopaminergic function are accentuated in +/- brain-derived neurotrophic factor mice.
    Dluzen DE, McDermott JL, Anderson LI, Kucera J, Joyce JN, Osredkar T, Walro JM.
    Neuroscience; 2004 Oct 15; 128(1):201-8. PubMed ID: 15450367
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC, Dluzen DE.
    Brain Res; 2004 Dec 17; 1029(2):186-94. PubMed ID: 15542073
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
    Callier S, Morissette M, Grandbois M, Pélaprat D, Di Paolo T.
    Synapse; 2001 Aug 17; 41(2):131-8. PubMed ID: 11400179
    [Abstract] [Full Text] [Related]

  • 13. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA.
    Synapse; 2005 Mar 15; 55(4):242-51. PubMed ID: 15668911
    [Abstract] [Full Text] [Related]

  • 14. Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system.
    Dluzen DE, Mickley KR.
    Pharmacol Biochem Behav; 2005 Jan 15; 80(1):27-33. PubMed ID: 15652377
    [Abstract] [Full Text] [Related]

  • 15. Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine.
    Kunnathur V, Shemisa K, Liu B, Salvaterra TJ, Dluzen DE.
    Neurotoxicol Teratol; 2006 Jan 15; 28(5):557-62. PubMed ID: 16978834
    [Abstract] [Full Text] [Related]

  • 16. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.
    Collier TJ, Dung Ling Z, Carvey PM, Fletcher-Turner A, Yurek DM, Sladek JR, Kordower JH.
    Exp Neurol; 2005 Feb 15; 191 Suppl 1():S60-7. PubMed ID: 15629762
    [Abstract] [Full Text] [Related]

  • 17. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Enna SJ, Reisman SA, Stanford JA.
    Neurosci Lett; 2006 Oct 02; 406(1-2):102-6. PubMed ID: 16890350
    [Abstract] [Full Text] [Related]

  • 18. Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice.
    Anderson LI, Leipheimer RE, Dluzen DE.
    Neuroscience; 2005 Oct 02; 130(2):369-82. PubMed ID: 15664693
    [Abstract] [Full Text] [Related]

  • 19. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice.
    Airavaara M, Planken A, Gäddnäs H, Piepponen TP, Saarma M, Ahtee L.
    Eur J Neurosci; 2004 Nov 02; 20(9):2336-44. PubMed ID: 15525275
    [Abstract] [Full Text] [Related]

  • 20. Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice.
    Baker SA, Stanford LE, Brown RE, Hagg T.
    Brain Res; 2005 Mar 28; 1039(1-2):177-88. PubMed ID: 15781060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.